157 related articles for article (PubMed ID: 33277302)
21. A Simplified Semiquantitative Meal Bolus Strategy Combined with Single- and Dual-Hormone Closed-Loop Delivery in Patients with Type 1 Diabetes: A Pilot Study.
Gingras V; Haidar A; Messier V; Legault L; Ladouceur M; Rabasa-Lhoret R
Diabetes Technol Ther; 2016 Aug; 18(8):464-71. PubMed ID: 27191385
[TBL] [Abstract][Full Text] [Related]
22. Advanced hybrid artificial pancreas system improves on unannounced meal response - In silico comparison to currently available system.
Garcia-Tirado J; Lv D; Corbett JP; Colmegna P; Breton MD
Comput Methods Programs Biomed; 2021 Nov; 211():106401. PubMed ID: 34560603
[TBL] [Abstract][Full Text] [Related]
23. Single- and Dual-Hormone Artificial Pancreas for Overnight Glucose Control in Type 1 Diabetes.
Haidar A; Rabasa-Lhoret R; Legault L; Lovblom LE; Rakheja R; Messier V; D'Aoust É; Falappa CM; Justice T; Orszag A; Tschirhart H; Dallaire M; Ladouceur M; Perkins BA
J Clin Endocrinol Metab; 2016 Jan; 101(1):214-23. PubMed ID: 26523526
[TBL] [Abstract][Full Text] [Related]
24. Reducing the need for carbohydrate counting in type 1 diabetes using closed-loop automated insulin delivery (artificial pancreas) and empagliflozin: A randomized, controlled, non-inferiority, crossover pilot trial.
Haidar A; Yale JF; Lovblom LE; Cardinez N; Orszag A; Falappa CM; Gouchie-Provencher N; Tsoukas MA; El Fathi A; Rene J; Eldelekli D; Lanctôt SO; Scarr D; Perkins BA
Diabetes Obes Metab; 2021 Jun; 23(6):1272-1281. PubMed ID: 33528904
[TBL] [Abstract][Full Text] [Related]
25. Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial.
Haidar A; Legault L; Matteau-Pelletier L; Messier V; Dallaire M; Ladouceur M; Rabasa-Lhoret R
Lancet Diabetes Endocrinol; 2015 Aug; 3(8):595-604. PubMed ID: 26066705
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of an Artificial Pancreas with Enhanced Model Predictive Control and a Glucose Prediction Trust Index with Unannounced Exercise.
Pinsker JE; Laguna Sanz AJ; Lee JB; Church MM; Andre C; Lindsey LE; Doyle FJ; Dassau E
Diabetes Technol Ther; 2018 Jul; 20(7):455-464. PubMed ID: 29958023
[TBL] [Abstract][Full Text] [Related]
27. Day-and-Night Closed-Loop Glucose Control in Patients With Type 1 Diabetes Under Free-Living Conditions: Results of a Single-Arm 1-Month Experience Compared With a Previously Reported Feasibility Study of Evening and Night at Home.
Renard E; Farret A; Kropff J; Bruttomesso D; Messori M; Place J; Visentin R; Calore R; Toffanin C; Di Palma F; Lanzola G; Magni P; Boscari F; Galasso S; Avogaro A; Keith-Hynes P; Kovatchev B; Del Favero S; Cobelli C; Magni L; DeVries JH;
Diabetes Care; 2016 Jul; 39(7):1151-60. PubMed ID: 27208331
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of single-hormone and dual-hormone artificial pancreas during continuous and interval exercise in adult patients with type 1 diabetes: randomised controlled crossover trial.
Taleb N; Emami A; Suppere C; Messier V; Legault L; Ladouceur M; Chiasson JL; Haidar A; Rabasa-Lhoret R
Diabetologia; 2016 Dec; 59(12):2561-2571. PubMed ID: 27704167
[TBL] [Abstract][Full Text] [Related]
29. Performance of the Omnipod Personalized Model Predictive Control Algorithm with Meal Bolus Challenges in Adults with Type 1 Diabetes.
Buckingham BA; Christiansen MP; Forlenza GP; Wadwa RP; Peyser TA; Lee JB; O'Connor J; Dassau E; Huyett LM; Layne JE; Ly TT
Diabetes Technol Ther; 2018 Sep; 20(9):585-595. PubMed ID: 30070928
[TBL] [Abstract][Full Text] [Related]
30. Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial.
Russell SJ; Hillard MA; Balliro C; Magyar KL; Selagamsetty R; Sinha M; Grennan K; Mondesir D; Ekhlaspour L; Zheng H; Damiano ER; El-Khatib FH
Lancet Diabetes Endocrinol; 2016 Mar; 4(3):233-243. PubMed ID: 26850709
[TBL] [Abstract][Full Text] [Related]
31. Fully Automated Artificial Pancreas for Adults With Type 1 Diabetes Using Multiple Hormones: Exploratory Experiments.
Majdpour D; Tsoukas MA; Yale JF; El Fathi A; Rutkowski J; Rene J; Garfield N; Legault L; Haidar A
Can J Diabetes; 2021 Dec; 45(8):734-742. PubMed ID: 33888413
[TBL] [Abstract][Full Text] [Related]
32. First Outpatient Clinical Trial of a Full Closed-Loop Artificial Pancreas System in South America.
Garelli F; Fushimi E; Rosales N; Arambarri D; Mendoza L; Serafini MC; Moscoso-Vásquez M; Stasi M; Duette P; García-Arabehety J; Giunta JN; De Battista H; Sánchez-Peña R; Grosembacher L
J Diabetes Sci Technol; 2023 Jul; 17(4):1008-1015. PubMed ID: 35549733
[TBL] [Abstract][Full Text] [Related]
33. A Randomized Crossover Trial to Compare Automated Insulin Delivery (the Artificial Pancreas) With Carbohydrate Counting or Simplified Qualitative Meal-Size Estimation in Type 1 Diabetes.
Haidar A; Legault L; Raffray M; Gouchie-Provencher N; Jafar A; Devaux M; Ghanbari M; Rabasa-Lhoret R
Diabetes Care; 2023 Jul; 46(7):1372-1378. PubMed ID: 37134305
[TBL] [Abstract][Full Text] [Related]
34. Overnight Glucose Control with Dual- and Single-Hormone Artificial Pancreas in Type 1 Diabetes with Hypoglycemia Unawareness: A Randomized Controlled Trial.
Abitbol A; Rabasa-Lhoret R; Messier V; Legault L; Smaoui M; Cohen N; Haidar A
Diabetes Technol Ther; 2018 Mar; 20(3):189-196. PubMed ID: 29393675
[TBL] [Abstract][Full Text] [Related]
35. Unannounced Meals in the Artificial Pancreas: Detection Using Continuous Glucose Monitoring.
Ramkissoon CM; Herrero P; Bondia J; Vehi J
Sensors (Basel); 2018 Mar; 18(3):. PubMed ID: 29547553
[TBL] [Abstract][Full Text] [Related]
36. Benefits of a bolus calculator in pre- and postprandial glycaemic control and meal flexibility of paediatric patients using continuous subcutaneous insulin infusion (CSII).
Shashaj B; Busetto E; Sulli N
Diabet Med; 2008 Sep; 25(9):1036-42. PubMed ID: 18937673
[TBL] [Abstract][Full Text] [Related]
37. Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.
El-Khatib FH; Balliro C; Hillard MA; Magyar KL; Ekhlaspour L; Sinha M; Mondesir D; Esmaeili A; Hartigan C; Thompson MJ; Malkani S; Lock JP; Harlan DM; Clinton P; Frank E; Wilson DM; DeSalvo D; Norlander L; Ly T; Buckingham BA; Diner J; Dezube M; Young LA; Goley A; Kirkman MS; Buse JB; Zheng H; Selagamsetty RR; Damiano ER; Russell SJ
Lancet; 2017 Jan; 389(10067):369-380. PubMed ID: 28007348
[TBL] [Abstract][Full Text] [Related]
38. Model-Based Detection and Classification of Insulin Pump Faults and Missed Meal Announcements in Artificial Pancreas Systems for Type 1 Diabetes Therapy.
Meneghetti L; Facchinetti A; Favero SD
IEEE Trans Biomed Eng; 2021 Jan; 68(1):170-180. PubMed ID: 32746034
[TBL] [Abstract][Full Text] [Related]
39. Flexible insulin therapy with a hybrid regimen of insulin degludec and continuous subcutaneous insulin infusion with pump suspension before exercise in physically active adults with type 1 diabetes (FIT Untethered): a single-centre, open-label, proof-of-concept, randomised crossover trial.
Aronson R; Li A; Brown RE; McGaugh S; Riddell MC
Lancet Diabetes Endocrinol; 2020 Jun; 8(6):511-523. PubMed ID: 32445738
[TBL] [Abstract][Full Text] [Related]
40. A New Meal Absorption Model for Artificial Pancreas Systems.
Diamond T; Cameron F; Bequette BW
J Diabetes Sci Technol; 2022 Jan; 16(1):40-51. PubMed ID: 33645257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]